FDA Searches for IT Skill Gaps as GAO Raps Its Technology Efforts

A new government report has cast doubt on the FDA’s ability to handle information associated with the rising flood of drug imports, saying its sluggishness in integrating legacy IT systems is limiting regulatory effectiveness. Compounding matters is its lack of a comprehensive list of existing and planned IT systems, according to the recent Government Accountability Office (GAO) analysis. And foot-dragging on standing up its largest mission-critical system modernization project — the Mission Accomplishments and Regulatory Compliance Services (MARCS) legacy systems replacement program — is of paramount concern, the report states.
Washington Drug Letter